ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells-Reference-Cited by-同舟云学术

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells

Published:2023-12 Issue:12 Volume:41 Page:2100-2116.e10
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Bergaggio Elisa,Tai Wei-Tien,Aroldi Andrea,Mecca Carmen,Landoni Elisa,Nüesch Manuel,Mota Ines,Metovic Jasna,Molinaro Luca,Ma Leyuan,Alvarado Diego,Ambrogio Chiara,Voena Claudia,Blasco Rafael B.,Li Tongqing,Klein Daryl,Irvine Darrell J.,Papotti Mauro,Savoldo Barbara,Dotti Gianpietro,Chiarle Roberto^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference75 articles.

1. Recent advances in neuroblastoma;Maris;N. Engl. J. Med.,2010

2. Neuroblastoma: biology, prognosis, and treatment;Park;Pediatr. Clin.,2008

3. Neuroblastoma: paradigm for precision medicine;Irwin;Pediatr. Clin.,2015

4. Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma;Pule;Nat. Med.,2008

5. CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma;Heczey;Mol. Ther.,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience;The Journal of Liquid Biopsy;2024-12

2. GD2 targeting CAR T cells for neuroblastoma;EJC Paediatric Oncology;2024-12

3. Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation;Scientific Reports;2024-09-09

4. Advances in dual-targeting inhibitors of HDAC6 for cancer treatment;European Journal of Medicinal Chemistry;2024-09

5. Emerging Cancer Immunotherapies: Cutting-Edge Advances and Innovations in Development;Medical Sciences;2024-08-28